GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Operating Cash Flow per Share

Vita Life Sciences (ASX:VLS) Operating Cash Flow per Share

: A$0.24 (TTM As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Vita Life Sciences's operating cash flow per share for the six months ended in Dec. 2023 was A$0.15. Vita Life Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.24.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Vita Life Sciences was 364.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vita Life Sciences's Operating Cash Flow per Share or its related term are showing as below:

ASX:VLS' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -23.6   Med: 11.3   Max: 102.1
Current: 18.3

During the past 13 years, Vita Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 102.10% per year. The lowest was -23.60% per year. And the median was 11.30% per year.

ASX:VLS's 3-Year OCF Growth Rate is ranked better than
64.19% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.7 vs ASX:VLS: 18.30

Vita Life Sciences Operating Cash Flow per Share Historical Data

The historical data trend for Vita Life Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.14 0.11 0.05 0.24

Vita Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Cash Flow per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - 0.05 0.08 0.15

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita Life Sciences Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's Price-to-Operating-Cash-Flow falls into.



Vita Life Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vita Life Sciences's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=12.982/54.699
=0.24

Vita Life Sciences's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=8.418/54.672
=0.15

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences (ASX:VLS) Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines